Pharmafile Logo
Pharmafocus logo
Advanced Search

regulatory

Showing 5 posts of 5 posts found.

mit

MIT-developed algorithm seeks to accelerate drug approvals during COVID-19 pandemic

May 20, 2020
Research and Development, Sales and Marketing COVID-19, MIT, coronavirus, regulatory

A study emerging from the Massachusetts Institute of Technology (MIT) and published in the Harvard Data Science Review has detailed strategies …

News
tanzania-sea-beach-zanzibar-paradise-africa-sand-3692068

WHO confirm Tanzania FDA as Africa’s first well-functioning regulatory body

December 11, 2018
Manufacturing and Production Africa, TFDA, Tanzania, WHO, regulation, regulatory

Tanzania has become the first country in Africa to achieve a well-functioning regulatory system for medical products, according to the …

News
diabetes-777001_960_720

Study reveals “concerning” low standards of type 2 diabetes drugs in India

March 7, 2018
Research and Development India, diabetes, pharma, regulatory, type 2 diabetes

In what they believe is the first study of its kind, a team of researchers at the University of Massachusetts …

News
lab

EMA accepts regulatory submission for proposed Herceptin biosimilar

August 26, 2016
Medical Communications Biocon, EMA, Herceptin, Mylan, biosimilar, regulatory, submission, trastuzumab

Mylan and Biocon have announced that the European Medicines Agency (EMA) has accepted for review its marketing authorisation application for …

News
EU image

Act now – or risk running out of time for IDMP

February 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Eversheds, ISO, icsr, idmp, regulatory

Many people in pharma would argue that the world of regulatory compliance in the life sciences industry is already complicated …

Feature

Latest content

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024

Intra-Cellular Therapies shares phase 3 results for major depressive disorder therapy

April 17, 2024

Novartis shares new data about Fabhalta for IgAN treatment

April 16, 2024